NASDAQ$WALD

Waldencast plc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Headline financials

Total Revenue

$142M

Previous: $94.4M+50.9%
EPS (adj)

-$2.45

Previous: -$0.30-716.7%
Capital Expenditures

$424K

Previous: $1.05M-59.8%
Free Cash Flow

-$71.4K

Previous: -$8.49M+99.2%
Net Income

-$19.4M

Previous: -$2.37M-720.7%
Operating Income

-$8.17M

Previous: $528K-1647.1%
Gross Profit

$0.00

Previous: $65.3M-100.0%
Cash & Equivalents

$12.8M

Previous: $8.57M+49.3%
Total Assets

$185M

Previous: $167K+110568.4%

Revenue & EPS history

Waldencast · Revenue · Quarterly

$142M

Q4 2021+50.9%vs Q4 2020
Beat estimate in 6 of 8 quarters(75%)
ActualEstimate

Revenue by segment

Waldencast · $65.4M total across 2 segments · Q1 2025

  • Milk Makeup
    $36.2M
  • Obagi Medical
    $29.2M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

-3.4%

Avg return

Earnings day

-4.7%

Avg return

5 days after

-6.5%

Avg return

30 days after

8%

1 / 12 earnings

Positive

+3.2%

Q3 2022

Best reaction

-19.5%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2025-19.5%-30.0%-27.4%
Q4 2024-3.3%-4.7%-20.7%
Q2 2024-0.3%+4.2%+23.1%
Q2 2023-0.3%+4.2%+23.1%
Q4 2023-0.4%-0.2%-17.6%
Q1 2024-0.3%-1.2%-25.1%
Q4 2022-12.3%-17.9%-22.2%
Q3 2023-0.1%-0.5%-14.4%
Q3 2022+3.2%+7.3%+5.1%
Q1 2023-7.7%-17.5%+0.1%
Q4 2021-0.2%-0.1%-0.1%
Q4 2020-0.1%+0.0%-1.8%
Q1 2022

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro